eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2011
vol. 28
 
Share:
Send email
Share:
abstract:

Review paper
Application of tacrolimus in the treatment of skin diseases other than atopic dermatitis

Wojciech Silny
,
Anna Sadowska
,
Aleksandra Dańczak-Pazdrowska
,
Adriana Polańska

Post Dermatol Alergol 2011; XXVIII, 1: 41–45
[Polish version: Post Dermatol Alergol 2011; XXVIII, 1: 47–52]
Online publish date: 2011/03/07
View full text Get citation
 
In dermatological therapy, a basic group of drugs with immunosuppressive and anti-inflammatory effects is the glucocorticoids. Their mechanism of action may lead to numerous side effects. The discovery of cyclosporin A, tacrolimus and pimecrolimus has created an alternative to steroid therapy in dermatology. A common feature of calcineurin inhibitors is inhibition of the activity of immunocompetent cells, which are responsible for inflammatory processes in the human body. Most studies on this group of drugs concern their effectiveness in the treatment of atopic dermatitis (AD). This paper presents a review of the literature concerning the use of tacrolimus in therapy of diseases other than AD.
keywords:

tacrolimus, calcineurin inhibitors, skin diseases
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.